questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Vascularite
Vascularite : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Vascularite
Biopsie
Imagerie médicale
Tests sanguins
Inflammation
Vitesse de sédimentation
Symptômes
Fatigue
Éruption cutanée
Biopsie
Diagnostic
Vascularite
Rhumatologie
Médecine interne
Vascularite
Symptômes
5
Symptômes
Fatigue
Éruption cutanée
Douleurs articulaires
Vascularite
Symptômes
Symptômes neurologiques
Vascularite
Engourdissement
Éruption cutanée
Purpura
Vascularite
Organes internes
Complications
Vascularite
Prévention
5
Prévention
Suivi médical
Vascularite
Vaccination
Prévention
Infections
Déclencheurs
Prévention
Vascularite
Suivi médical
Vascularite
Traitement
Alimentation
Antioxydants
Vascularite
Traitements
5
Corticostéroïdes
Immunosuppresseurs
Traitement
Corticostéroïdes
Inflammation
Vascularite
Immunosuppresseurs
Vascularite
Traitement
Thérapies biologiques
Vascularite
Traitement
Traitement
Vascularite
Suivi médical
Complications
5
Complications
Lésions organiques
Vascularite
Insuffisance rénale
Complications
Vascularite
Risques cardiovasculaires
AVC
Vascularite
Complications
Traitement
Vascularite
Surveillance
Examens médicaux
Vascularite
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Vascularite
Âge
Facteurs de risque
Vascularite
Infections
Déclencheurs
Vascularite
Tabagisme
Facteurs de risque
Vascularite
Maladies auto-immunes
Facteurs de risque
Vascularite
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vascularite : Questions médicales les plus fréquentes",
"headline": "Vascularite : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vascularite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vascularite"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies vasculaires",
"url": "https://questionsmedicales.fr/mesh/D014652",
"about": {
"@type": "MedicalCondition",
"name": "Maladies vasculaires",
"code": {
"@type": "MedicalCode",
"code": "D014652",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aortite",
"alternateName": "Aortitis",
"url": "https://questionsmedicales.fr/mesh/D001025",
"about": {
"@type": "MedicalCondition",
"name": "Aortite",
"code": {
"@type": "MedicalCode",
"code": "D001025",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.080"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Artérite",
"alternateName": "Arteritis",
"url": "https://questionsmedicales.fr/mesh/D001167",
"about": {
"@type": "MedicalCondition",
"name": "Artérite",
"code": {
"@type": "MedicalCode",
"code": "D001167",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.090"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Endartérite",
"alternateName": "Endarteritis",
"url": "https://questionsmedicales.fr/mesh/D004692",
"about": {
"@type": "MedicalCondition",
"name": "Endartérite",
"code": {
"@type": "MedicalCode",
"code": "D004692",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.090.340"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Cogan",
"alternateName": "Cogan Syndrome",
"url": "https://questionsmedicales.fr/mesh/D055952",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Cogan",
"code": {
"@type": "MedicalCode",
"code": "D055952",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phlébite",
"alternateName": "Phlebitis",
"url": "https://questionsmedicales.fr/mesh/D010689",
"about": {
"@type": "MedicalCondition",
"name": "Phlébite",
"code": {
"@type": "MedicalCode",
"code": "D010689",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thrombophlébite",
"alternateName": "Thrombophlebitis",
"url": "https://questionsmedicales.fr/mesh/D013924",
"about": {
"@type": "MedicalCondition",
"name": "Thrombophlébite",
"code": {
"@type": "MedicalCode",
"code": "D013924",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Lemierre",
"alternateName": "Lemierre Syndrome",
"url": "https://questionsmedicales.fr/mesh/D057831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Lemierre",
"code": {
"@type": "MedicalCode",
"code": "D057831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Lemierre",
"alternateName": "Lemierre Syndrome",
"url": "https://questionsmedicales.fr/mesh/D057831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Lemierre",
"code": {
"@type": "MedicalCode",
"code": "D057831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vascularite rétinienne",
"alternateName": "Retinal Vasculitis",
"url": "https://questionsmedicales.fr/mesh/D031300",
"about": {
"@type": "MedicalCondition",
"name": "Vascularite rétinienne",
"code": {
"@type": "MedicalCode",
"code": "D031300",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.815"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vascularite systémique",
"alternateName": "Systemic Vasculitis",
"url": "https://questionsmedicales.fr/mesh/D056647",
"about": {
"@type": "MedicalCondition",
"name": "Vascularite systémique",
"code": {
"@type": "MedicalCode",
"code": "D056647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.897"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thromboangéite oblitérante",
"alternateName": "Thromboangiitis Obliterans",
"url": "https://questionsmedicales.fr/mesh/D013919",
"about": {
"@type": "MedicalCondition",
"name": "Thromboangéite oblitérante",
"code": {
"@type": "MedicalCode",
"code": "D013919",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.905"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vascularite",
"alternateName": "Vasculitis",
"code": {
"@type": "MedicalCode",
"code": "D014657",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David S Younger",
"url": "https://questionsmedicales.fr/author/David%20S%20Younger",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu."
}
},
{
"@type": "Person",
"name": "Tanaz A Kermani",
"url": "https://questionsmedicales.fr/author/Tanaz%20A%20Kermani",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA."
}
},
{
"@type": "Person",
"name": "Christian Pagnoux",
"url": "https://questionsmedicales.fr/author/Christian%20Pagnoux",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto."
}
},
{
"@type": "Person",
"name": "Cristina Ponte",
"url": "https://questionsmedicales.fr/author/Cristina%20Ponte",
"affiliation": {
"@type": "Organization",
"name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com."
}
},
{
"@type": "Person",
"name": "Nikita Khmelinskii",
"url": "https://questionsmedicales.fr/author/Nikita%20Khmelinskii",
"affiliation": {
"@type": "Organization",
"name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Activation of the complement system by nanoparticles and strategies for complement inhibition.",
"datePublished": "2023-11-08",
"url": "https://questionsmedicales.fr/article/37949325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejpb.2023.11.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pitfalls in complement analysis: A systematic literature review of assessing complement activation.",
"datePublished": "2022-10-18",
"url": "https://questionsmedicales.fr/article/36330514",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1007102"
}
},
{
"@type": "ScholarlyArticle",
"name": "Factors affecting IgG4-mediated complement activation.",
"datePublished": "2023-01-26",
"url": "https://questionsmedicales.fr/article/36776883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1087532"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complement activation and kidney transplantation; a complex relationship.",
"datePublished": "2023-06-02",
"url": "https://questionsmedicales.fr/article/37276614",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.imbio.2023.152396"
}
},
{
"@type": "ScholarlyArticle",
"name": "Significance of urine complement proteins in monitoring lupus activity.",
"datePublished": "2022-11-18",
"url": "https://questionsmedicales.fr/article/36420131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.14383"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vascularite",
"item": "https://questionsmedicales.fr/mesh/D014657"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vascularite - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vascularite",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vascularite",
"description": "Comment diagnostiquer une vascularite ?\nQuels tests sanguins sont utilisés ?\nQuels symptômes indiquent une vascularite ?\nLa biopsie est-elle toujours nécessaire ?\nQuels spécialistes consultent pour une vascularite ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Activation#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vascularite",
"description": "Quels sont les symptômes courants de la vascularite ?\nLa vascularite peut-elle causer des douleurs articulaires ?\nY a-t-il des symptômes neurologiques associés ?\nLes éruptions cutanées sont-elles spécifiques ?\nLa vascularite peut-elle affecter les organes internes ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Activation#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vascularite",
"description": "Peut-on prévenir la vascularite ?\nLes vaccinations sont-elles recommandées ?\nComment éviter les déclencheurs ?\nLe suivi médical est-il important ?\nY a-t-il des conseils diététiques ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Activation#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vascularite",
"description": "Quels traitements sont disponibles pour la vascularite ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand utilise-t-on des immunosuppresseurs ?\nY a-t-il des traitements alternatifs ?\nLe traitement est-il à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Activation#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vascularite",
"description": "Quelles sont les complications possibles de la vascularite ?\nLa vascularite peut-elle entraîner des problèmes rénaux ?\nQuels risques cardiovasculaires sont associés ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Activation#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vascularite",
"description": "Quels sont les facteurs de risque de la vascularite ?\nL'âge influence-t-il le risque de vascularite ?\nLes infections peuvent-elles déclencher une vascularite ?\nLe tabagisme est-il un facteur de risque ?\nCertaines maladies auto-immunes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Activation#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une vascularite ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la vitesse de sédimentation et les marqueurs inflammatoires sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une vascularite ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent fatigue, fièvre, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle toujours nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est souvent utilisée si les tests sanguins ne sont pas concluants."
}
},
{
"@type": "Question",
"name": "Quels spécialistes consultent pour une vascularite ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les rhumatologues et les médecins internistes sont souvent impliqués dans le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la vascularite ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle causer des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs articulaires sont fréquentes et peuvent être sévères."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maux de tête, des troubles de la vision et des engourdissements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles spécifiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent varier, mais souvent apparaissent sous forme de plaques ou de purpura."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle affecter les organes internes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut toucher les reins, les poumons et le cœur, entraînant des complications."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la vascularite ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent la vascularite."
}
},
{
"@type": "Question",
"name": "Comment éviter les déclencheurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, le stress et les infections peut réduire les risques de poussées."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut soutenir la santé vasculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la vascularite ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les immunosuppresseurs sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et soulagent les symptômes rapidement."
}
},
{
"@type": "Question",
"name": "Quand utilise-t-on des immunosuppresseurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour les cas graves ou réfractaires aux corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques peuvent être envisagées dans certains cas spécifiques."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité et de la réponse au traitement, souvent plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la vascularite ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions organiques, des AVC et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle entraîner des problèmes rénaux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer une insuffisance rénale aiguë ou chronique."
}
},
{
"@type": "Question",
"name": "Quels risques cardiovasculaires sont associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent avoir un risque accru de maladies cardiaques et d'AVC."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement précoce."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de fonction organique sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la vascularite ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de vascularite ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de vascularite sont plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles déclencher une vascularite ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections virales ou bactériennes peuvent être des déclencheurs."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de vascularite."
}
},
{
"@type": "Question",
"name": "Certaines maladies auto-immunes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde sont des facteurs de risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu.
Publications dans "Vascularite" :
3 publications dans cette catégorie
Affiliations :
Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA.
Publications dans "Vascularite" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals, Leeds, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: e.brouwer@umcg.nl.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Division of Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Hacettepe University Vasculitis Research Center, Ankara, Turkey.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology and Division of Clinical Epidemiology, University of Pennsylvania, Philadelphia, PA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Musgrove Park Hospital, Taunton, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK matthew.wells@nbt.nhs.uk.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic, Phoenix, Arizona, USA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Publications dans "Vascularite" :
The complement system is a multicomponent and multifunctional arm of the innate immune system. Complement contributes to non-specific host defence and maintains homeostasis through multifaceted proces...
The complement system is an essential component of our innate defense and plays a vital role in the pathogenesis of many diseases. Assessment of complement activation is critical in monitoring both di...
We performed a systematic analysis of the current methods used to assess complement components and reviewed whether the identified studies performed their complement measurements according to the reco...
A literature search using the Pubmed/MEDLINE database was performed focusing on studies measuring the key complement components C3, C5 and/or their split products and/or the soluble variant of the ter...
A total of 92 out of 376 studies were selected for full-text analysis. Forty-five studies (49%) were identified as using the correct sample type and techniques for their complement analyses, while 25 ...
A substantial part of the reviewed studies did not use the appropriate sample type for assessing complement activation or did not mention which sample type was used. This deviation from the standardiz...
Of the four human immunoglobulin G (IgG) subclasses, IgG4 is considered the least inflammatory, in part because it poorly activates the complement system. Regardless, in IgG4 related disease (IgG4-RD)...
Although kidney transplantation is the best treatment for end stage kidney disease, the benefits are limited by factors such as the short fall in donor numbers, the burden of immunosuppression and gra...
Complement activation is a critical feature in the development of systemic lupus erythematosus (SLE). Whether there are changes of complement components in the urine of SLE has not been reported. The ...
First, we used bioinformatics and functional enrichment to screen and identify the urine protein profile of SLE patients. Then, analyzed and verified the proteins related to the complement pathway by ...
A total of 14 complement pathway-related proteins were screened for differences in expression between the active group and the stable group, eight of these DEPs were up-regulated and six were down-reg...
Complement-related DEPs in urine have a certain correlation with SLE disease activity. Urine C9, C8A, C4B and C8G present promising non-invasive biomarkers for monitoring lupus activity....
Vaginal microbiome and the local innate immune defense, including the complement system, contribute to anti- and proinflammatory homeostasis during pregnancy and parturition. The relationship between ...
To study the association of the cervicovaginal microbiota composition to activation and regulation of the complement system during pregnancy and labor....
We recruited women during late pregnancy (weeks 41 + 5 to 42 + 0, n=48) and women in active labor (weeks 38 + 4 to 42 + 2, n=25). Mucosal swabs were taken from the external cervix and lateral fornix o...
The vaginal microbiota was...
These results indicate that bacterial composition of the vaginal microbiota could have a role in the local activation and regulation of complement-mediated inflammation during pregnancy. At the time o...
Histopathologic studies have identified immunoglobulin (Ig) deposition and complement activation as contributors of CNS tissue damage in multiple sclerosis (MS). Intrathecal IgM synthesis is associate...
CC and CAP levels were quantified in plasma and CSF of 112 patients with clinically isolated syndrome (CIS), 127 patients with MS (90 relapsing-remitting, 14 primary progressive, and 23 secondary prog...
CSF (but not plasma) levels of C3a, C4a, Ba, and Bb were increased in patients with CIS/MS, being most pronounced in those with an additional intrathecal IgM production. In CIS, doubling of C3a and C4...
CNS-compartmentalized activation of the classical and alternative pathways of complement is increased in CIS/MS and associated with the presence of an intrathecal IgM production. Increased complement ...
Several studies have shown the importance of the complement and coagulation systems in the pathogenesis of asthma....
We explored whether we could detect differentially abundant complement and coagulation proteins in the samples obtained from the small airway lining fluid by collection of exhaled particles in patient...
Exhaled particles were obtained from 20 subjects with asthma and 10 healthy controls (HC) with the PExA method and analysed with the SOMAscan proteomics platform. Lung function was assessed by nitroge...
53 proteins associated with the complement and coagulation systems were included in the analysis. Nine of those proteins were differentially abundant in subjects with asthma as compared to HC, and C3 ...
The study highlights the role of the local activation of the complement and coagulation systems in the small airway lining fluid in asthma and their association with both asthma control and small airw...
Central line associated bloodstream infections (CLABSI) with...
Malignant nephrosclerosis is a thrombotic microangiopathy associated with abnormal local activation of the complement alternative pathway (AP). However, the mechanism underlying local AP activation is...